Home

Capstone Nursing Project

Alvimopan : for better patient outcomes.

Reference URL

To link to this object, paste this link in email, IM or document
To embed this object, paste this HTML in website

Alvimopan : for better patient outcomes.

View Description

small (250x250 max)

medium (500x500 max)

Large

Extra Large

large ( > 500x500)

Full Resolution

This item is restricted to only allow viewing of the metadata.

you wish to report:

Your comment:

Your Name:

...

Select the collections to add or remove from your search

Select All Collections

American Nurse Project

Bully Project

GCU Alumni Archives

GCU CONHCP Authors

Proquest Dissertations

Cancel

Title	Alvimopan : for better patient outcomes.
Subject	Intestines, Obstructions; Surgery, Complications; Defecation disorders.
Description	Abdominal surgery is one of most common surgeries performed today. The complications of such a surgery can be devastating. PostOperative Ileus (POI) is a common complication and is estimated to occur in up to 25% of all abdominal surgeries (Vather & Bissett, 2013). POI causes pain, discomfort, abdominal distension, constipation, and can extend the hospital stay costing billions of dollars annually (Hiranyakas, et al, 2011. pg 109). As medical professionals, it is our job to facilitate positive outcomes for out patients. By utilizing resources that were unheard of just 10 years ago, we can assist in reducing time spent hospitalized after an abdominal surgery. Utiliziation of all resources available; fast track recovery programs and medications such as Alvimopan, we can decrease the occurrence of POI and facilitate a positive outcome for post-abdominal surgery patients. Alvimopan is an opioid antagonist that reverses many unwanted effects of opioids without affecting centrally mediated analgesia (Linn, & Steinbrook, 2007. pg 27). This article discusses the steps a small surgical hospital in Arlington, Texas is taking to approve and establish a standing set of orders, for all postabdominal surgery patients. Included in these orders is the use of the medication Alvimopan. Alvimopan has been proven to decrease the occurrence of POI by 44% while decreasing the length of hospitalization for those with diagnosed POI by up to 50% (Hilton, et al, 2012. pg 1054), and diminishing the complications associated with an extended hospital stay.
Creator	Clark, Scott.
Publisher	Grand Canyon University
Date	2014
Type	text
Format	PDF
Identifier	EBN_2014_Clark_S_1168
Source	2014_Clark_S_1168.pdf
Language	eng